S. Alibhai, H. Breunis, N. Timilshina, R. Brignardello-petersen, G. Tomlinson et al., Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age, Journal of Geriatric Oncology, vol.6, issue.4, pp.262-71, 2015.
DOI : 10.1016/j.jgo.2015.04.002

H. Mohamedali, H. Breunis, N. Timilshina, J. Brandwein, V. Gupta et al., Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia, Leukemia Research, vol.36, issue.10, pp.1241-1249, 2012.
DOI : 10.1016/j.leukres.2012.05.020

C. Mackall, T-Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review, Stem Cells, vol.9, issue.1, pp.10-18, 2000.
DOI : 10.1056/NEJM198107093050202

URL : http://onlinelibrary.wiley.com/doi/10.1634/stemcells.18-1-10/pdf

B. Hermann, N. Lehners, M. Brodhun, K. Boden, A. Hochhaus et al., Influenza virus infections in patients with malignancies ?????? characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO), European Journal of Clinical Microbiology & Infectious Diseases, vol.85, issue.Suppl 1, pp.565-73, 2017.
DOI : 10.1097/01.md.0000232560.22098.4e

A. Wong, T. Marrie, S. Garg, J. Kellner, G. Tyrrell et al., Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies, Epidemiology and Infection, vol.26, issue.12, pp.1804-1814, 2010.
DOI : 10.1111/j.1365-3083.1989.tb01119.x

T. Yamada, Y. Nannya, A. Suetsugu, S. Shimizu, J. Sugihara et al., Late Reactivation of Hepatitis B Virus after Chemotherapies for Hematological Malignancies: A Case Report and Review of the Literature, Internal Medicine, vol.56, issue.1, pp.115-123, 2017.
DOI : 10.2169/internalmedicine.56.7468

T. Ercan, L. Soycan, H. Apak, T. Celkan, A. Ozkan et al., Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia, Journal of Pediatric Hematology/Oncology, vol.27, issue.5, pp.273-280, 2005.
DOI : 10.1097/01.mph.0000163214.37147.5a

A. Puthillath, D. Trump, C. Andrews, A. Bir, K. Romano et al., Serological immune responses to influenza vaccine in patients with colorectal cancer, Cancer Chemotherapy and Pharmacology, vol.12, issue.10, pp.111-116, 2011.
DOI : 10.3109/10428199909167399

J. Robertson, K. Nagesh, S. Jowitt, M. Dougal, H. Anderson et al., Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma, British Journal of Cancer, vol.82, issue.7, pp.1261-1266, 2000.
DOI : 10.1054/bjoc.1999.1088

R. Villena, M. Zubieta, C. Hurtado, C. Salgado, G. Silva et al., Seroconversi??n frente a primovacunaci??n reforzada contra hepatitis B en ni??os con c??ncer, Revista Chilena de Pediatr??a, vol.86, issue.4, pp.236-279, 2015.
DOI : 10.1016/j.rchipe.2015.06.012

URL : https://doi.org/10.1016/j.rchipe.2015.06.012

N. Eliakim-raz, I. Vinograd, Z. Trestioreanu, A. Leibovici, L. Paul et al., Influenza vaccines in immunosuppressed adults with cancer, Cochrane Database Syst Rev, vol.24, issue.6940, p.8983, 2013.
DOI : 10.1086/513648

URL : http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008983.pub2/pdf

L. Torre, G. Mannocci, A. Colamesta, V. , D. Egidio et al., Influenza and pneumococcal vaccination in hematological malignancies: a systematic review of efficacy, effectiveness and safety, Mediterranean Journal of Hematology and Infectious Diseases, vol.8, issue.1, p.2016044, 2016.
DOI : 10.4084/mjhid.2016.044

A. Monier, M. Puyade, P. Bouchaert, J. Tourani, X. Leleu et al., Enquête sur la vaccination des patients d'onco

Y. Urun, H. Akbulut, A. Demirkazik, C. Senler, F. Utkan et al., Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members, J BUON Off J Balk Union Oncol. juin, vol.18, issue.2, pp.511-516, 2013.

F. Lachenal, C. Sebban, M. Duruisseaux, P. Biron, J. Blay et al., Influenza vaccination in patients with haematologic malignancies: analysis of practices in 200 patients in a single center, Bull Cancer avr, vol.97, issue.4, pp.33-36, 2010.

W. Poeppl, H. Lagler, M. Raderer, W. Sperr, C. Zielinski et al., Influenza vaccination perception and coverage among patients with malignant disease, Vaccine, vol.33, issue.14, pp.1682-1689, 2015.
DOI : 10.1016/j.vaccine.2015.02.029

M. Toleman, K. Herbert, N. Mccarthy, and D. Church, Vaccination of chemotherapy patients--effect of guideline implementation. Support Care Cancer Off J Multinatl Assoc Support Care Cancer, pp.2317-2338, 2016.

/. Données and . Couverture-vaccinale, Maladies à prévention vaccinale / Maladies infectieuses / Dossiers thématiques / Accueil Disponible sur: http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies- a-prevention-vaccinale

J. Guthmann, L. Fonteneau, I. Bonmarin, and D. Lévy-bruhl, Enquête nationale de couverture vaccinale, France, janvier 2011, Couv Vaccinale Contre Grippe Saison Dans Groupes Cibles Mes L'efficacité Vaccinale Couv Vaccinale Par Vaccins

C. Richard, L. Garlantezec, P. Lamand, V. Rasamijao, V. Rapp et al., Couverture vaccinale anti-pneumococcique chez des patients ?? risque hospitalis??s??: ??valuation et propositions d???am??lioration, Annales Pharmaceutiques Fran??aises, vol.74, issue.3, pp.244-51, 2016.
DOI : 10.1016/j.pharma.2015.10.007

P. Loulergue, O. Mir, J. Alexandre, S. Ropert, F. Goldwasser et al., Low influenza vaccination rate among patients receiving chemotherapy for cancer, Annals of Oncology, vol.19, issue.9, pp.1658-1658, 2008.
DOI : 10.1093/annonc/mdn531

URL : https://academic.oup.com/annonc/article-pdf/19/9/1658/549169/mdn531.pdf

Z. Tang, X. Li, S. Wu, Y. Liu, Y. Qiao et al., Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis, Hepatology International, vol.11, issue.5, 2017.
DOI : 10.1002/hep.29082

L. Mozessohn, K. Chan, J. Feld, and L. Hicks, Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis, Journal of Viral Hepatitis, vol.57, issue.3, pp.842-851, 2015.
DOI : 10.1016/j.jcv.2013.03.010

L. Hsiao, T. Chiou, J. Gau, C. Yang, Y. Yu et al., Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients, Medicine, vol.94, issue.32, p.1321, 2015.
DOI : 10.1097/MD.0000000000001321

L. , &. -. #+%-&-"-3m, %. &. , and #. C#1, 9:%))*+$=&,(#3*1"%&)%2#%1--1)&'*)&E#%, )012% & $N1+O%2"1(-(71%&$%&-N3P'1"*-&$%&8-%)#"1(+,&'%)6%""*+"&#+%&+37,235308%3)1'9$'(, pp.1-1

-. , &. %&, *. +%, &. $. , &. *. et al., 121121, (6=& 2(+O()6/6%+"&J&-*&-(1&U&1+O()6*"1E#%&%"&-1D%1&$#&W&K*+01%)&HXYZ&)%-*"10%&J&-.1+O()6*"1E#%=&*#R& O1231%),&%"&*#R&-1D%%R%)2%&J&"(#"&6(6%+"&%"&E#%&0(#,&'(#0%4&'*)&2(+,/E#%+"&O*1)%&0*-(1)&0(")%&$)(1"&$% & )%2"1O12*"1(+&%"&$.(''(,1"1(+&*#R&$(++/%,&E#%&0(#,&+(#,&*#)%4&")*+, p.61